New York launches generic drug manufacturing partnerships

File S01618 ("New York launches generic drug manufacturing partnerships") is before the New York Legislature and has not been decided. Latest step (February 24, 2026): referred to health.

New York file S01618, before the New York Legislature. Still to be decided as of 2026-02-24.

What it does

Lower generic drug prices through state manufacturing partnerships New York residents and insurers may pay less for generic prescription drugs if state partnerships successfully increase competition and reduce supply-chain bottlenecks that artificially raise prices.

The bigger picture

Reduced drug costs ripple through public health budgets Medicaid, Medicare, and state employee health plans would face lower drug procurement costs, potentially freeing resources for other health services or reducing pressure on taxpayer contributions.

How they voted

Yes (47)

No (9)

Did not vote / other (7)

Read the official record for S01618

See everything up for a vote · This week in New York · See what we have filed with the clerk